Table 2.

Recommended dosing of UFH and LMWH in neonates and children.

UFH i.v.Neonates < 5kgChildren > 5kgTarget aPTT at 4h
* 1 mg Enoxaparin = 110 anti-FXa units 
For UFH: aPTT 4 hours after loading dose and 4 hours after each dosage adjustment, at least once daily; keep AT level within normal range; daily blood count (platelets!). For LMWH: anti-FX activity 4 hours after injection 
loading dose 1 × 75 U/kg/10 min 1 × 75 U/kg/10 min  
maintenance 25–30 U/kg/h 20 U/kg/h 60–85 sec. 
LMWH s.c. Neonates < 5kg Children > 5kg Target anti-FXa at 4 h 
initial treatment dose 
Enoxaparin* 1 × 2.0 mg/kg/d 1 × 1.5 mg/kg/d 0.4–0.8 U/mL 
Dalteparin 1 × 200 U/kg/d 1 × 150 U/kg/d 0.4–0.8 U/mL 
Reviparin 2 × 150 U/kg/d 2 × 100 U/kg/d 0.5–1.0 U/mL 
initial prophylactic dose 
Enoxaparin* 1 × 1.5 mg/kg/d 1 × 1.0 mg/kg/d < 0.4 U/mL 
Dalteparin 1 × 100 U/kg/d 1 × 50 U/kg/d < 0.4 U/mL 
Reviparin 2 × 50 U/kg/d 2 × 30 U/kg/d < 0.5 U/mL 
UFH i.v.Neonates < 5kgChildren > 5kgTarget aPTT at 4h
* 1 mg Enoxaparin = 110 anti-FXa units 
For UFH: aPTT 4 hours after loading dose and 4 hours after each dosage adjustment, at least once daily; keep AT level within normal range; daily blood count (platelets!). For LMWH: anti-FX activity 4 hours after injection 
loading dose 1 × 75 U/kg/10 min 1 × 75 U/kg/10 min  
maintenance 25–30 U/kg/h 20 U/kg/h 60–85 sec. 
LMWH s.c. Neonates < 5kg Children > 5kg Target anti-FXa at 4 h 
initial treatment dose 
Enoxaparin* 1 × 2.0 mg/kg/d 1 × 1.5 mg/kg/d 0.4–0.8 U/mL 
Dalteparin 1 × 200 U/kg/d 1 × 150 U/kg/d 0.4–0.8 U/mL 
Reviparin 2 × 150 U/kg/d 2 × 100 U/kg/d 0.5–1.0 U/mL 
initial prophylactic dose 
Enoxaparin* 1 × 1.5 mg/kg/d 1 × 1.0 mg/kg/d < 0.4 U/mL 
Dalteparin 1 × 100 U/kg/d 1 × 50 U/kg/d < 0.4 U/mL 
Reviparin 2 × 50 U/kg/d 2 × 30 U/kg/d < 0.5 U/mL 

or Create an Account

Close Modal
Close Modal